Literature DB >> 27575344

A Review of Healthcare Failure Mode and Effects Analysis (HFMEA) in Radiotherapy.

M Giardina1, M C Cantone, E Tomarchio, I Veronese.   

Abstract

This paper presents a review of risk analyses in radiotherapy (RT) processes carried out by using Healthcare Failure Mode Effect Analysis (HFMEA) methodology, a qualitative method that proactively identifies risks to patients and corrects medical errors before they occur. This literature review was performed to provide an overview of how to approach the development of HFMEA applications in modern RT procedures, comparing recently published research conducted to support proactive programs to identify risks. On the basis of the reviewed literature, the paper suggests HFMEA shortcomings that need to be addressed.

Entities:  

Mesh:

Year:  2016        PMID: 27575344     DOI: 10.1097/HP.0000000000000536

Source DB:  PubMed          Journal:  Health Phys        ISSN: 0017-9078            Impact factor:   1.316


  3 in total

1.  An Assessment of the Knowledge, Attitude, and Practice Toward Standard Precautions Among Health Workers From a Hospital in Northern Cyprus.

Authors:  Gulifeiya Abuduxike; Songul Acar Vaizoglu; Ozen Asut; Sanda Cali
Journal:  Saf Health Work       Date:  2020-09-11

2.  Applying Healthcare Failure Mode and Effect Analysis and the Development of a Real-Time Mobile Application for Modified Early Warning Score Notification to Improve Patient Safety During Hemodialysis.

Authors:  Chang-Hung Lin; Tsing-Fen Ho; Hui-Fen Chen; Hsin-Yi Chang; Ju-Huei Chien
Journal:  J Patient Saf       Date:  2022-02-03       Impact factor: 2.243

3.  Implementation of Failure Mode and Effects Analysis to the specimens flow in a population-based colorectal cancer screening programme using immunochemical faecal occult blood tests: a quality improvement project in the Milan colorectal cancer screening programme.

Authors:  Silvia Deandrea; Enrica Tidone; Aldo Bellini; Luigi Bisanti; Nico Gerardo Leonardo; Anna Rita Silvestri; Dario Consonni
Journal:  BMJ Open Qual       Date:  2018-03-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.